Abstract
Hypertension is the leading risk factor for end-stage renal disease (ESRD). However, the association between sustained exposure to increased blood pressure (BP) and ESRD is not well established. This study investigated whether the cumulative hypertension burden is a substantial risk factor for ESRD. The incidence of ESRD among 2,144,801 participants identified from the Korean National Health Insurance Service database who had documented BP assessment data in their annual health check-up data from between 2006 and 2010, was determined. Over a median follow-up of 7.2 years, ESRD was identified in 1758 participants. Hypertension burden was defined as the cumulative exposure to hypertension (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) during four consecutive follow-up periods and ranged from 0 to 4. The hypertension burden was as follows: 0 (n = 1,164,488), 77.6%; 1 (n = 292,377), 13.6%; 2 (n = 114,397), 5.3%; 3 (n = 52,671), 2.5%; and 4 (n = 20,886), 1.0%. Compared to the hypertension burden of 0, the adjusted hazard ratio for ESRD was 1.35, 1.54, 1.51, and 2.28 for hypertension burdens of 1, 2, 3, and 4, respectively. A positive dose-dependent relationship between hypertension burden and ESRD was found (P for interaction < 0.001). This association was maintained for sustained exposure to both systolic and diastolic hypertension burden. In conclusion, hypertension burden increases the risk of ESRD. Our study underlines the usefulness of a new assessment of the hypertension burden over a certain period for predicting the risk of ESRD in a large population-based cohort.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Anonymized data are publicly available from the National Health Insurance Sharing Service and can be accessed at https://nhiss.nhis.or.kr/bd/ab/bdaba000eng.do.
References
Leiba A, Fishman B, Twig G, Gilad D, Derazne E, Shamiss A, et al. Association of Adolescent Hypertension With Future End-stage Renal Disease. JAMA Intern Med. 2019;179:517–23.
Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005;165:923–8.
Bell EK, Gao L, Judd S, Glasser SP, McClellan W, Gutierrez OM, et al. Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease. Am J Hypertens. 2012;25:789–96.
Nwabuo CC, Appiah D, Moreira HT, Vasconcellos HD, Yano Y, Reis JP, et al. Long-term cumulative blood pressure in young adults and incident heart failure, coronary heart disease, stroke, and cardiovascular disease: the CARDIA study. Eur J Prev Cardiol. 2020; https://doi.org/10.1177/2047487320915342):2047487320915342.
Kramer H, Colangelo L, Lewis CE, Jacobs DR Jr., Pletcher M, Bibbins-Domingo K, et al. Cumulative Exposure to Systolic Blood Pressure During Young Adulthood Through Midlife and the Urine Albumin-to-Creatinine Ratio at Midlife. Am J Hypertens. 2017;30:502–9.
Bae EH, Lim SY, Han KD, Oh TR, Choi HS, Kim CS, et al. Association Between Systolic and Diastolic Blood Pressure Variability and the Risk of End-Stage Renal Disease. Hypertension. 2019;74:880–7.
Kim CS, Han KD, Choi HS, Bae EH, Ma SK, Kim SW. Association of Hypertension and Blood Pressure With Kidney Cancer Risk: a Nationwide Population-Based Cohort Study. Hypertension. 2020;75:1439–46.
Kim CS, Han KD, Choi HS, Bae EH, Ma SK, Kim SW. Association of Body Mass Index and Waist Circumference with All-Cause Mortality in Hemodialysis Patients. J Clin Med. 2020;9:1289.
Lee SR, Park CS, Choi EK, Ahn HJ, Han KD, Oh S, et al. Hypertension Burden and the Risk of New-Onset Atrial Fibrillation: a Nationwide Population-Based Study. Hypertension. 2021;77:919–28.
Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function–measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–83.
Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract. 2007;75:72–80.
Teramoto K, Nadruz Junior W, Matsushita K, Claggett B, John JE, Skali H, et al. Mid- to Late-Life Time-Averaged Cumulative Blood Pressure and Late-Life Cardiac Structure, Function, and Heart Failure. Hypertension. 2020;76:808–18.
Itoga NK, Tawfik DS, Lee CK, Maruyama S, Leeper NJ, Chang TI. Association of Blood Pressure Measurements With Peripheral Artery Disease Events. Circulation. 2018;138:1805–14.
Mahinrad S, Kurian S, Garner CR, Sedaghat S, Nemeth AJ, Moscufo N, et al. Cumulative Blood Pressure Exposure During Young Adulthood and Mobility and Cognitive Function in Midlife. Circulation. 2020;141:712–24.
Jenkins LM, Garner CR, Kurian S, Higgins JP, Parrish TB, Sedaghat S, et al. Cumulative Blood Pressure Exposure, Basal Ganglia, and Thalamic Morphology in Midlife. Hypertension. 2020;75:1289–95.
Zhou B, Li C, Shou J, Zhang Y, Wen C, Zeng C. The cumulative blood pressure load and target organ damage in patients with essential hypertension. J Clin Hypertens (Greenwich, Conn). 2020;22:981–90.
Kim TH, Yang PS, Yu HT, Jang E, Shin H, Kim HY, et al. Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population. Eur Heart J. 2019;40:809–19.
Parati G, Stergiou GS, Dolan E, Bilo G. Blood pressure variability: clinical relevance and application. J Clin Hypertens (Greenwich, Conn). 2018;20:1133–7.
Kishi S, Teixido-Tura G, Ning H, Venkatesh BA, Wu C, Almeida A, et al. Cumulative Blood Pressure in Early Adulthood and Cardiac Dysfunction in Middle Age: the CARDIA Study. J Am Coll Cardiol. 2015;65:2679–87.
Pletcher MJ, Bibbins-Domingo K, Lewis CE, Wei GS, Sidney S, Carr JJ, et al. Prehypertension during young adulthood and coronary calcium later in life. Ann Intern Med. 2008;149:91–9.
McMullan CJ, Lambers Heerspink HJ, Parving HH, Dwyer JP, Forman JP, de Zeeuw D. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial. Am J Kidney Dis: Off J Natl Kidney Found. 2014;64:714–22.
Whittle J, Lynch AI, Tanner RM, Simpson LM, Davis BR, Rahman M, et al. Visit-to-Visit Variability of BP and CKD Outcomes: results from the ALLHAT. Clin J Am Soc Nephrol. 2016;11:471–80.
Gosmanova EO, Mikkelsen MK, Molnar MZ, Lu JL, Yessayan LT, Kalantar-Zadeh K, et al. Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease. J Am Coll Cardiol. 2016;68:1375–86.
Tsai WC, Wu HY, Peng YS, Yang JY, Chen HY, Chiu YL, et al. Association of Intensive Blood Pressure Control and Kidney Disease Progression in Nondiabetic Patients With Chronic Kidney Disease: a Systematic Review and Meta-analysis. JAMA Intern Med. 2017;177:792–9.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.
Nakayama M, Sato T, Miyazaki M, Matsushima M, Sato H, Taguma Y, et al. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study. Hypertens Res. 2011;34:1106–10.
Acknowledgements
This work was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI18C0331, HR20C0021) and by a grant (BCRI20062, BCRI21023) from Chonnam National University Hospital Biomedical Research Institute.
Author information
Authors and Affiliations
Contributions
CSK, KH, and SWK contributed to the study design. BK, HSC, EHB, SKM, and KH collected the data. CSK, BK, and KH performed the statistical analysis. CSK prepared the first draft of the paper. All the authors contributed intellectually to the revision of the article and approved the final version.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Kim, C.S., Kim, B., Choi, H.S. et al. Cumulative hypertension burden and risk of end-stage renal disease. Hypertens Res 44, 1652–1661 (2021). https://doi.org/10.1038/s41440-021-00723-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-021-00723-0